A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP)
The prevalence of poor response to gonadotropin stimulation is approximately 9–24% in women undergoing in vitro fertilization. Interestingly, due to containing a variety of growth factors, platelet-rich plasma (PRP) can play an important role in tissue regeneration and healing. Thus, in this research, we aimed to investigate the intra-ovarian injection of PRP in women with poor ovarian response. To this goal, 23 poor responders constituted the study population, from among whom 19 women were enrolled. These patients underwent ovarian stimulation according to the Shanghai protocol. Immediately after the first follicular puncture, 2 mL of PRP was injected into each ovary. 1 day after the first puncture and PRP injection, the second stimulation was initiated. Then, oocyte retrieval was followed. About 2–3 months after the first cycle, the patients underwent another treatment with ovarian stimulation according to the Shanghai protocol and then, follicular puncture was performed. The mean numbers of oocytes before and after PRP injection were 0.64 and 2.1, respectively. Two patients experienced spontaneous conceptions. The third case achieved clinical pregnancy and delivered a healthy baby in June 2018. The results of this study appeared to be the first report on the effects of intra-ovarian PRP injection on the increase of ovarian responses, even on the spontaneous conceptions of women with poor ovarian response.
KeywordsPlatelet rich plasma Ovary Infertility Poor ovarian response Pregnancy
The study was funded by vice-chancellor for Research and Technology, Hamadan University of Medical Sciences, Iran (Grant No. 960115299).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 4.Moffat R, Pirtea P, Gayet V, Wolf JP, Chapron C, de Ziegler D (2014) Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technnology is limited. Reprodu BioMed Online 29(6):659–661. https://doi.org/10.1016/j.rbmo.2014.08.010 CrossRefGoogle Scholar
- 6.Murase T, Iwase A, Komatsu K, Bayasula, Nakamura T, Osuka S, Takikawa S, Goto M, Kotani T, Kikkawa F (2017) Follicle dynamics: visualization and analysis of follicle growth and maturation using murine ovarian tissue culture. J Assist Reprod Genet. https://doi.org/10.1007/s10815-017-1073-5 CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Fung M, Grossman B, Hillyer C, Westhoff C (2014) American assocation of blood banks. Technical manual, 18th edn. American Association of Blood Banks, Bethesda, pp 645–661Google Scholar
- 19.Bassiouny YA, Dakhly DMR, Bayoumi YA, Hashish NM (2016) Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? a randomized, controlled trial. Fertil Steril 105(3):697–702CrossRefPubMedGoogle Scholar
- 27.Vitt U, Hayashi M, Klein C, Hsueh A (2000) Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 62(2):370–377CrossRefPubMedGoogle Scholar
- 28.Pantos K, Nitsos N, Kokkali G, Vaxevanoglou T, Markomichali C, Pantou A, Grammatis M, Lazaros L, Sfakianoudis K Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment. In: Abstracts, ESHRE 32nd Annual Meeting (2016) pp 3–6Google Scholar
- 30.Sfakianoudis K, Simopoulou M, Nitsos N, Rapani A, Pantou A, Vaxevanoglou T, Kokkali G, Koutsilieris M, Pantos K (2018) A case series on platelet-rich plasma revolutionary management of poor responder patients. Gynecol Obstet Investig 84:1–8Google Scholar
- 31.Van Blerkom J, Antczak M, Schrader R (1997) The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod (Oxford England) 12(5):1047–1055CrossRefGoogle Scholar
- 33.Modlich U, Kaup F-J, Augustin HG (1996) Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Investig; J Tech Methods Pathol 74(4):771–780Google Scholar